FDA · 药品动态·· 18 天前AI 评分38
竞争对手Inovio罕见病药物获FDA批准,PGEN股价盘后暴跌27%
PGEN Stock Craters 27% After-Hours After Rival Inovio's Rare Disease Drug Receives FDA Approval - Stocktwits
AI 导读
竞争对手Inovio的罕见病药物获FDA批准后,PGEN股价盘后暴跌27%。
来源:FDA · 药品动态 · news.google.com
PGEN Stock Craters 27% After-Hours After Rival Inovio's Rare Disease Drug Receives FDA Approval - Stocktwits
竞争对手Inovio的罕见病药物获FDA批准后,PGEN股价盘后暴跌27%。
来源:FDA · 药品动态 · news.google.com